The phase 3 NETTER-1 study of [(177)Lu-]Lu-DOTA-TATE in patients with midgut neuroendocrine tumours: Final overall survival and long-term renal safety Meeting Abstract
| Authors: | Kunz, P.; Caplin, M. E.; Ruszniewski, P. B.; Bodei, L.; Hendifar, A.; Mittra, E.; Wolin, E. M.; Yao, J. C.; Pavel, M. E.; Grande, E.; Van Cutsem, E.; Seregni, E.; Duarte, H.; Demange, A.; Mutevelic, S.; Strosberg, J. R.; Krenning, E. P. |
| Abstract Title: | The phase 3 NETTER-1 study of [(177)Lu-]Lu-DOTA-TATE in patients with midgut neuroendocrine tumours: Final overall survival and long-term renal safety |
| Meeting Title: | 2021 Annual Congress of the European Association of Nuclear Medicine (EANM'21) |
| Journal Title: | European Journal of Nuclear Medicine and Molecular Imaging |
| Volume: | 48 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2021 Oct 20-23 |
| Meeting Location: | Virtual |
| ISSN: | 1619-7070 |
| Publisher: | Springer |
| Date Published: | 2021-09-01 |
| Start Page: | S188 |
| Language: | English |
| ACCESSION: | WOS:000709355000306 |
| PROVIDER: | wos |
| PMCID: | PMC8461591 |
| PUBMED: | 34559267 |
| DOI: | 10.1007/s00259-021-05547-1 |
| Notes: | Meeting Abstract: OP-0527 -- Source: Wos |
